Vicat : One could take advantage of the market's hesitation
Entry price | Target | Stop-loss | Potential |
---|
€39.45 |
€42.4 |
€38.35 |
+7.48% |
---|
Vicat have been fluctuating horizontally for several weeks. As the share price returns to the lower bound of the accumulation zone, it yoffers a good timing for investors to open new long positions.
Strengths● The share is getting closer to its long-term support in weekly data, at EUR 37.9, which offers good timing for buyers.
● The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
● The company's attractive earnings multiples are brought to light by a P/E ratio at 11.95 for the current year.
● This company will be of major interest to investors in search of a high dividend stock.
● Analysts covering this company mostly recommend stock overweighting or purchase.
● The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses● The group shows a rather high level of debt in proportion to its EBITDA.
● Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
● Revenue estimates are regularly revised downwards for the current and coming years.
● For the last few months, analysts have been revising downwards their earnings forecast.
● For the past year, analysts have significantly revised downwards their profit estimates.
● The underlying tendency is negative on the weekly chart below the resistance at 43.7 EUR
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.